Research on semaglutide medications shows that weight loss often slows and begins to level off after about a year of treatment
If people are sensitive to caffeine, I recommend they avoid caffeinated beverages completely, recommends Lynn Grieger, RDN, CDCES, a health, food, and fitness coach in private practice in Chromo, Colorado, and a medical reviewer for Everyday Health
Coverage unavailable when GLP-1 coverable under Part D benefit Beneficiaries who are prescribed Wegovy or Zepbound for a use that is coverable under the basic Medicare Part D benefit, regardless of whether the drug is on the Part D plans formulary (e.g., Zepbound for the treatment of moderate to severe obstructive sleep apnea in adults with obesity, or Wegovy to reduce the risk of major adverse cardiovascular (CV) events in adults with established CV disease who are either obese or overweight), will not qualify for coverage of that drug under the Bridge Program
Men who prioritize strength training during GLP-1 therapy consistently report better body composition outcomes than those who rely on the appetite suppression alone